ArticleACS nano2025
Chiroptical Control of Gold Nanoparticle Growth through Combination of a Multimodal Chirality Inducer and Surfactant Counterion.
Article in ACS nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A First-Principles Study of l‑Glutathione Adsorption on Chiral Gold Nanoparticles.ACS materials Au · 2026Article
- Chirality Transfer via Orientational Order of Micellar Assemblies on Gold Nanocrystals.Advanced materials (Deerfield Beach, Fla.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chiral plasmonic nanomaterials display strong interactions with circularly polarized light, offering significant potential in chirality sensing, enantioselective catalysis, and biomedical applications. While recent advances in seeded-growth synthesis have yielded complex chiral gold nanostructures through chemically induced or micelle-directed growth mechanisms, detailed intercorrelated mechanisms remain elusive. In this context, we have systematically investigated the versatility of the chiral inducer 2-amino-N-decyl-3-mercaptopropanamide (LipoCYS), which incorporates both an amino acid moiety and an aliphatic chain designed to bridge both established mechanisms. By employing cubic and octahedral achiral gold seeds and varying the surfactant halides, along with the concentration of LipoCYS, we generated a wide range of chiral morphologies, from twisted helicoids to intricate wrinkled spheres and intermediate structures. Advanced electron microscopy, including electron tomography, enabled comprehensive three-dimensional characterization and revealed distinct chiral morphological transitions and their correlations with chiroptical properties. Excellent agreement was found with the simulation results, thereby validating the representativeness of the microscopic analysis. Our findings expand the synthetic toolbox available for the precise control of nanoparticle chirality, providing deeper insights into the mechanisms of chiral growth and enhancing their potential for tailored applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.